| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/01/2009 | EP1623719B1 Treatment of alzheimer's disease and cerebral amyloid angiopathy |
| 07/01/2009 | EP1536833B1 Vaccine against yersinia comprising one or two antibodies, one specific for yersinia pestis f1-antigen and the other one for yersina pestis v-antigen |
| 07/01/2009 | EP1527100B1 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 07/01/2009 | EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/01/2009 | EP1377165B1 Tsg101-gag interaction and use thereof |
| 07/01/2009 | EP1351967B1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/01/2009 | EP1261704B1 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 07/01/2009 | EP1203025B1 Novel method and composition for inhibition of angiogenesis using antagonists based on mmp-9 and beta1 integrins |
| 07/01/2009 | EP1104310B1 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response |
| 07/01/2009 | EP1019068B1 Therapeutic formulations containing snake and/or insect venom for the prophylaxis and therapy of neoplasms |
| 07/01/2009 | EP0915973B1 Gene involved in cadasil, method of diagnosis and therapeutic application |
| 07/01/2009 | EP0871748B1 Delivery of biologically active polypeptides |
| 07/01/2009 | EP0784688B1 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 07/01/2009 | CN101472611A Methods of modulating IL-22 and IL-17 |
| 07/01/2009 | CN101472610A Recombinant viral vaccine |
| 07/01/2009 | CN101472609A Method for the preparation of specific antibodies against saccharidic antigens |
| 07/01/2009 | CN101472608A Influenza vaccines containing hemagglutinin and matrix proteins |
| 07/01/2009 | CN101472607A Novel DNA sequences, vectors and proteins of avian influenza hemagglutinin |
| 07/01/2009 | CN101472606A Methods for the treatment of flavivirus infection, molecules and uses thereof |
| 07/01/2009 | CN101472605A Pharmaceutical composition for the sublingual administration of vaccines, method for the preparation of the same and uses thereof |
| 07/01/2009 | CN101472604A Viable non-toxic gram negative bacteria |
| 07/01/2009 | CN101469017A Synthetic peptide vaccines for foot-and-mouth disease |
| 07/01/2009 | CN101468202A PIL-12 gene adjuvant for pig vaccine and method for preparing the same |
| 07/01/2009 | CN101468201A Preparation of mycobacterium tuberculosis polyvalent recombinant protein vaccine |
| 07/01/2009 | CN100506989C Mosaic infections bursal disease virus vaccines |
| 07/01/2009 | CN100506846C Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 07/01/2009 | CN100506293C Coating that promotes endothelial Cell adherence |
| 07/01/2009 | CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 06/30/2009 | USRE40811 Administering anti-VLA-4 antibody (or anti-VCAM-1 antibody) which blocks binding VLA-4 antigen on surface of CD34 cells to VCAM-1 or fibronectin, thereby increasing number of CD34+ cells in peripheral blood; colony stimulating factors |
| 06/30/2009 | US7555152 System and method for detecting ground glass nodules in medical images |
| 06/30/2009 | US7553953 For the treatment and diagnosis of various cancers including carcinoma, gastrointestinal, colorectal, colon or ovarian cancer; colon-specific antigen-p mucin (CSAp) antigen |
| 06/30/2009 | US7553944 A nucleotide sequence along with the deduced amino acid sequences of the complete genomic sequence of a novel human coronavirus (CoV-HKU1) of the order Nidovirales; single-stranded RNA virus of positive polarity; immunogenic/vaccine preparations using recombinant and chimeric forms; vectors; cells |
| 06/30/2009 | US7553939 Genes that encode cell surface molecules with conserved IgV and mucin domains; diagnosis or staging of cancer; treatment of an immunological disorder; detecting a predisposition to asthma |
| 06/30/2009 | US7553938 Purification process of gamma-globulins from human plasma and other sources; using caprylate combined with or replaced by heptanoate to perform precipitation and incubation; anion exchange chromatography |
| 06/30/2009 | US7553936 Triggering receptors expressed on myeloid cells (TREMs) specific immunoglobulin for use in prevention and treatment of blood coagulation disorders |
| 06/30/2009 | US7553929 Administering nuclear factor kappa beta (nf-kb)peptide nuclear localization sequence to inhibit import of stress-responsive transcription factor; septic shock, skin disorders, autoimmune diseases |
| 06/30/2009 | US7553918 pH-sensitive polymer |
| 06/30/2009 | US7553814 Cancer drug target; useful in diagnostic, prophylactic, prognostic, of certain cancers |
| 06/30/2009 | US7553810 Methods and compositions for sealing localized regions of damaged lung tissue to reduce overall lung volume, glue featuring an adhering moiety coupled to one or more other moieties including a cross-linkable moiety and/or one other adhering moiety; use in treating pulmonary conditions, emphysema, copd |
| 06/30/2009 | US7553634 Lysis, fermentation, diafiltration |
| 06/30/2009 | US7553618 Method for determining human immunodeficiciency virus type 1 (HIV-1) hypersusceptibility to the protease inhibitor amprenavir |
| 06/30/2009 | US7553496 VEGF-A as an inhibitor of angiogenesis and methods of using same |
| 06/30/2009 | US7553494 WT1 fusion proteins |
| 06/30/2009 | US7553493 Chlamydia flagellar protein antigen |
| 06/30/2009 | US7553492 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 06/30/2009 | US7553491 BIVM (basic, immunoglobulin-like variable motif-containing) gene, transcriptional products, and uses thereof |
| 06/30/2009 | US7553490 Use of polysaccharides containing the tetrasaccharide repeat unit to induce serum antibodies having bactericidal activity against hemolytic-uremic syndrome (HUS) causing E. coli, in particular E. coli O157 |
| 06/30/2009 | US7553489 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| 06/30/2009 | US7553488 Chemokine inhibitors; for treatment of gout; for inhibiting migration of neutrophils involved in pathogenesis |
| 06/30/2009 | US7553487 Method and compositions for treating asthma |
| 06/30/2009 | US7553486 Anti-VEGF treatment for radiation-induced vasculopathy |
| 06/30/2009 | US7553485 Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof |
| 06/30/2009 | US7553484 Modulating neuronal outgrowth via the major histocompatibility complex class I (MHC I) molecule |
| 06/30/2009 | US7553483 Chemokine mutants acting as chemokine antagonists |
| 06/30/2009 | CA2619381A1 Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases |
| 06/30/2009 | CA2324970C Improved immunodiagnostic assays using reducing agents |
| 06/30/2009 | CA2286399C Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 06/30/2009 | CA2161445C Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 06/30/2009 | CA2133106C Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
| 06/30/2009 | CA2108119C Glial mitogenic factors, their preparation and use |
| 06/30/2009 | CA2095521C Hepatitis c virus asialoglycoproteins |
| 06/30/2009 | CA2057052C Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
| 06/25/2009 | WO2009079585A2 Compositions and methods for treating osteolytic disorders comprising mmp-14 binding proteins |
| 06/25/2009 | WO2009079471A1 Method for treating bone fracture with anti-sclerostin antibodies |
| 06/25/2009 | WO2009079382A1 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 06/25/2009 | WO2009079242A2 Aglycosylated immunoglobulin mutants |
| 06/25/2009 | WO2009079066A2 Therapeutic and vaccine polyelectrolyte nanoparticle compositions |
| 06/25/2009 | WO2009078799A1 New vaccine for the treatment of mycobacterium related disorders |
| 06/25/2009 | WO2009078796A1 Compositions and methods for treatment of autoimmune and allergic diseases |
| 06/25/2009 | WO2009078445A1 Pharmaceutical preparation |
| 06/25/2009 | WO2009077854A2 Adjuvanted glucans |
| 06/25/2009 | WO2009077744A2 Vaccines for brucellosis |
| 06/25/2009 | WO2009077577A2 Vaccine antigens from piscirickettsia salmonis |
| 06/25/2009 | WO2009077483A1 Antibodies against human nkg2d and uses thereof |
| 06/25/2009 | WO2009077479A2 Altering high-density lipoprotein levels through carboxylesterase 1 modulation |
| 06/25/2009 | WO2009076966A2 Rhoc-based immunotherapy |
| 06/25/2009 | WO2009076824A1 Genes encoding major capsid protein l1 of human papilloma virus's |
| 06/25/2009 | WO2009076778A1 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
| 06/25/2009 | WO2009076775A1 Immune response modulation and uses thereof |
| 06/25/2009 | WO2009061407A4 Schistosoma vaccine |
| 06/25/2009 | WO2009054873A9 Anti-rantes antibodies and methods of use thereof |
| 06/25/2009 | WO2009053683A3 Treatment of inflammatory diseases |
| 06/25/2009 | WO2009053038A3 Combination therapy of a type ii anti-cd20 antibody with a proteasome inhibitor |
| 06/25/2009 | WO2009050403A3 Patch with hydrophilic adhesive |
| 06/25/2009 | WO2009048839A3 Vaccinia virus h3l and b5r specific monoclonal antibodies and methods of making and using same |
| 06/25/2009 | WO2009046123A3 Nlrr-1 antagonists and uses thereof |
| 06/25/2009 | WO2009043051A3 Cd23 binding molecules and methods of use thereof |
| 06/25/2009 | WO2009017833A3 Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis |
| 06/25/2009 | WO2009009591A9 Use of cells to facilitate targeted delivery of nanoparticle therapies |
| 06/25/2009 | WO2009000825A3 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
| 06/25/2009 | WO2008142479A3 Intergenic sites between conserved genes in the genome of modified vaccinia ankara (mva) vaccinia virus |
| 06/25/2009 | WO2008103431A3 Dnai - liposomes |
| 06/25/2009 | WO2008076278A4 Methods of cancer treatment with igf1r inhibitors |
| 06/25/2009 | WO2007024743A3 Proteolysis resistant antibody preparations |
| 06/25/2009 | US20090165152 Mesothelin Vaccines and Model Systems |
| 06/25/2009 | US20090163420 Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid beta, prion protein, amylin, alpha-synuclein, or polyglutamine repeats for induction of an immune response thereto |
| 06/25/2009 | US20090162935 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 06/25/2009 | US20090162933 Epha2 and hyperproliferative cell disorders |
| 06/25/2009 | US20090162918 Baculovirus expressing the exogenous nucleotide sequence porcine circovirus-B (PCVB) open reading frame 2; transformed host cells for expressing immunogenic protein for protecting pigs including pregnant pigs; adjuvant |
| 06/25/2009 | US20090162850 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer |